Lonza  
Careers @ Lonza | Contact us | Sitemap |
Shop
 
Home > Company > Media Center > News Archive > 2001 > Lonza Group announces expansion plans in microbial fermentation
 
Lonza Group announces expansion plans in microbial fermentation
send     print    
Media Releases Financial Reports Presen-tations
10/11/2001      
Lonza Group's Business Sector Biotec announces today that it plans to expand its cGMP microbial fermentation manufacturing capacity at its Kourim (CZ) facility.


In order to cope with the increasing demand for microbial fermentation services, Lonza has committed to an expansion of its Kourim (CZ) facility. With the completion of this invest-ment totalling CHF 85 million, the fermentation capacity will be increased by 50% and new Downstream-Processing capabilities and supporting utilities will be added. The cGMP compliant plant is due to come on stream in the fourth quarter of 2003.

"We are extremely pleased to assure our customers access to Lonza's world class facilities and expertise in microbial fermentation," says René Imwinkelried, Head of Lonza Biotec. "The decision to expand our capacity and capabilities in cGMP microbial fermentation underscores Lonza's commitment to strengthen its leadership position. The new plant forms part of a global expansion program in our biotechnology custom manufacturing services."

Lonza Biotec is part of Lonza Group and is the leader in contract development and manufacturing of therapeutic ingredients and intermediates based on its 20 years of experience in microbial fermentation. The company undertakes specialized services for the pharmaceutical, biotechnology and nutrition industries. With headquarters in Basel (CH), Lonza Biotec operates R&D and cGMP multi-product manufacturing facilities in Visp, Switzerland and Kourim, Czech Republic.

Lonza Group is a Life Sciences driven chemical company headquartered in Switzerland, with sales of CHF 1.7 billion in 2000 and operating 13 facilities in 6 countries. It employs 4700 people worldwide and is the leading supplier of active chemical ingredients, intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries. It also offers a broad catalogue of organic intermediates for a wide range of applications such as pharmaceuticals, agrochemicals, vitamins, food and feedstuff, dyes and pigments, adhesives and fragrances. Furthermore the Group manufactures specialty biocides and oleochemicals.

For further information please contact:
Dr. Walter Eschenmoser
Communications/Investor Relations
Tel +41 61 316 8363
Fax +41 61 316 8220
walter.eschenmoser@lonzagroup.com


Disclaimer